Work

Outcomes by EGFR, KRAS and ALK Genotype After Combined Modality Therapy for Locally Advanced Non-Small Cell Lung Cancer

Year: 2016

Type: article

Study design: Observational Study

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2016.06.378

Authors: R.H. Mak, G. Hermann, H. Aerts, A.B. Chen, E.H. Baldini, D.E. Kozono, Y.H. Chen, P.J. Catalano, P. Janne

Institutions: Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, Brigham and Women's Hospital, Harvard University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2526316788

FWCI:

Cites:

Cited by: 4

Related to: 10